News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 La FA Subclínica es Común en Pacientes Asintomáticos de Mayor Edad Todd Neale November 18, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Daily News New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women Shelley Wood October 19, 2016
News Daily News Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests Todd Neale October 19, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News A-fib Screening With Smartphone-Based ECG Feasible, but Clinical Impact Unclear Todd Neale October 13, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes Todd Neale September 28, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Daily News Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo Todd Neale September 26, 2016
News Daily News Alcohol and the Heart: Boozing May Boost A-fib Risk by Enlarging the Left Atrium Todd Neale September 14, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 Edoxaban Shows Safety, Efficacy for A-fib Patients Undergoing Cardioversion: ENSURE-AF Todd Neale August 30, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016